Reduction of transepidermal water loss by oral intake of glucosylceramides in patients with atopic eczema.
Miyanishi
K
K
R&D Center, Unitika Ltd. 23, Kozakura-Uji Uji City Kyoto Prefecture 611-0021, Japan. km-miyanishi@unitika.co.jp
Shiono
N
N
Shirai
H
H
Dombo
M
M
Kimata
H
H
D000284:Administration, Oral; D000328:Adult; D031056:Amorphophallus / Q000737:chemistry*; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000378:metabolism; D004334:Drug Administration Schedule; D005260:Female; D005963:Glucosylceramides / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012867:Skin / Q000378:metabolism; D014867:Water / Q000032:analysis / Q000378:metabolism
D005963:Glucosylceramides; D014867:Water